iSOFT Partners with Southampton on Groundbreaking Life Science Project

iSOFTiSOFT, a CSC company, and University Hospital Southampton NHS Foundation Trust are to jointly explore using new software to extract and anonymise clinical information for research and clinical trials, in one of the first projects of its type in the UK.

"Clinical information held by NHS trusts is of huge value in clinical research and offers these trusts a potential income stream," said Dr Joerg Kraenzlein, iSOFT's director of life sciences. "A key goal is to prove that our solution is able to extract a broader range of clinical information than is currently possible and at a fraction of the time and cost.

"Current methods normally involve trawling through records manually, which is time consuming and unreliable as records are often missed or lack relevance. The project will potentially save months in the planning and execution phase of clinical trials," Kraenzlein said.

Under the project, CliniWorks' AccelFind software will be interfaced to Southampton's clinical systems to extract and de-identify information about cancers and other diseases, and heart and blood conditions from one million records. It will also collect and structure information on diagnoses, treatments, medications and outcomes into a format that supports research and clinical trials.

Southampton has a history of identifying patients for clinical trials. The city’s partnership between the University of Southampton and University Hospital Southampton NHS Foundation Trust saw 13,464 patients recruited to clinical trials during 2010-11, making it the one of the top three centres in England.

Adrian Byrne, Southampton's chief information officer, said: “Southampton is already a leader in involving patients in research programmes and we are happy that we can work with iSOFT to improve this and ensure that more patients obtain access to the latest and best treatments."

iSOFT signalled its intent to move into the life sciences space, after agreeing a deal with US-based CliniWorks for AccelFind, which is developed to extract medical knowledge from any type of data, including free text notes, discharge summaries or the structured data found in electronic medical records.

"Drug development is an extremely expensive business and typically costs up to US$1 billion to bring a single drug to market," Kraenzlein said.

"The process of recruiting patients for clinical trials is the most critical element, causing 80% of trials to run over time and budget, with an average of 90 days and £1.3 million in lost sales, so anything that reduces time and cost will interest pharmaceutical companies greatly.

"Through our partnership with Southampton and CliniWorks, we can move to developing solutions which will speed the feasibility and patient recruitment processes and so help execute trials on time and budget."

iSOFT's chief medical officer, Dr Michael Dahlweid, said: "This is a beacon project which paves the way for healthcare organisations to move beyond collecting data for use during patient care, to using the data for advanced analysis, prediction and improved drug discovery. The potential benefits to patients are significant."

"The ability to extract meaningful information from various data sources and formats is a challenge in today's healthcare IT systems," says Nitzan Sneh, CliniWorks' chief executive officer. "Leveraging technology that can aggregate and analyse all types of medical data will allow for better management of healthcare treatment and costs, as well as provide clinicians with the ability to better understand health outcomes."

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...